Compare Star Pacific Tbk (LPLI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Pacific Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Star Pacific Tbk trades at Rp236 (market cap 276.22B, 309.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Star Pacific Tbk is far larger — about 2.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LPLI | SCPI | |
|---|---|---|
Market Cap | 276.22B | 104.4B |
Volume | 309.9K | — |
Lot | 3.1K | — |
Turnover | 73.14M | — |
Average Price | 236 | — |
Value | 73.14M | — |
Indicative Equilibrium Price | 236 | — |
Indicative Equilibrium Volume | 8 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Pacific Tbk
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Read more on LPLI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
